NIH Weekly Funding Opportunities and Policy Notices
Funding Opportunity RFA-CA-23-021 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) is one of three FOAs that will support a comprehensive effort by the National Cancer Institute (NCI) to provide infrastructure to develop and conduct national cancer screening clinical trials and studies through the Cancer Screening Research Network (CSRN). The primary goal of the CSRN is the conduct of multi-center cancer screening trials and studies. This Network is designed to take advantage of large and diverse populations receiving routine care in a variety of healthcare settings. The CSRN will engage these populations in rigorous studies focused on cancer screening to improve early cancer detection and evaluate emerging cancer screening modalities with the ultimate goal of reducing cancer incidence, and cancer-related morbidity and mortality.
Funding Opportunity RFA-CA-23-020 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) is one of three FOAs that will support a comprehensive effort by the National Cancer Institute (NCI) to provide infrastructure to develop and conduct national cancer screening clinical trials and studies through the Cancer Screening Research Network (CSRN). The primary goal of the CSRN is the conduct of multi-center cancer screening trials and studies. This Network is designed to take advantage of large and diverse populations receiving routine care in a variety of healthcare settings. The CSRN will engage these populations in rigorous studies focused on cancer screening to improve early cancer detection and evaluate emerging cancer screening modalities with the ultimate goal of reducing cancer incidence, and cancer-related morbidity and mortality.
Notice NOT-HS-23-003 from the NIH Guide for Grants and Contracts
Notice NOT-OD-23-021 from the NIH Guide for Grants and Contracts
Notice NOT-AR-23-007 from the NIH Guide for Grants and Contracts
Notice NOT-HS-23-004 from the NIH Guide for Grants and Contracts
Notice NOT-DK-23-003 from the NIH Guide for Grants and Contracts
Notice NOT-HG-23-014 from the NIH Guide for Grants and Contracts
Notice NOT-HL-22-056 from the NIH Guide for Grants and Contracts
Notice NOT-OD-23-018 from the NIH Guide for Grants and Contracts
Notice NOT-DA-22-064 from the NIH Guide for Grants and Contracts
Notice NOT-CA-23-012 from the NIH Guide for Grants and Contracts
Notice NOT-AR-23-011 from the NIH Guide for Grants and Contracts
Notice NOT-AR-23-010 from the NIH Guide for Grants and Contracts
Notice NOT-MH-23-125 from the NIH Guide for Grants and Contracts
Funding Opportunity RFA-DA-23-059 from the NIH Guide for Grants and Contracts. Sleep and circadian dysfunctions are frequently co-morbid with opioid use disorder (OUD) and may have clinical utility in identifying individuals at risk for poor treatment response and relapse. The goals of this program are a) to uncover novel mechanisms underlying the bidirectional interrelationship between sleep/circadian rhythm and OUD, and b) to reveal new insights into sleep and/or circadian-based predictors of OUD medication treatment response and outcomes.
Funding Opportunity RFA-DA-23-060 from the NIH Guide for Grants and Contracts. Applications are invited from institutions to participate as the Leadership and Data Coordinating Center (LDCC) for the Sleep Predictors of Opioid Use Disorders (OUD) Treatment and Outcomes Program. The overall goals of this program are a) to uncover novel mechanisms underlying the bidirectional interrelationship between sleep/circadian rhythm and OUD, and b) to delineate sleep and/or circadian-based predictors of OUD treatment response and outcomes. The Leadership and Data Coordination Center will lead, coordinate and analyze data for a multi-site common protocol focused on sleep/circadian rhythm measures. The data will be used to develop a predictive model of OUD medication treatment response and outcomes.
Funding Opportunity RFA-DA-24-002 from the NIH Guide for Grants and Contracts. This broad PAR will support exploratory studies addressing mechanistic questions in HIV infection, replication, latency, and/or pathogenesis (including HAND) in the context of SUDs.
Notice NOT-HS-23-002 from the NIH Guide for Grants and Contracts
Notice NOT-OD-23-019 from the NIH Guide for Grants and Contracts